Congratulations on your letter to the President and the Secretary which details your suggested next steps in implementing the National HIV/AIDS Strategy.
The AIDS Institute is asking you to support an increase of at least $106 million, which is the authorized level under the Ryan White HIV/AIDS Treatment Extension Act of 2009.
We ask you to keep the ADAP crisis at the top of your agenda and to continue to urge the Obama Administration to address this situation. Asking states to lower eligibility requirements, which HRSA is now doing, is not an answer.
Written Statement of Carl Schmid, Deputy Executive Director, The AIDS Institute to the Subcommittee on Labor, Health and Human Services, Education, and Related Agencies House Committee on Appropriations
PUBLIC COMMENT by CARL SCHMID, DEPUTY EXECUTIVE DIRECTOR, THE AIDS INSTITUTE
before the PRESIDENTIAL ADVISORY COUNCIL ON HIV/AIDS
January 27, 2011
Washington, DC
The AIDS Institute would particularly like the Committees to focus on increased funding for the Ryan White AIDS Drug Assistance Program (ADAP) and HIV prevention funding at the Centers for Disease Control and Prevention (CDC). November 4, 2010 Washington, DC
Public Comment by James Sykes, Director of Global Policy, The AIDS Institute before the Food and Drug Administration Approval Pathway for Biosimilar and Interchangeable Products November 2, 2010 Washington, DC
Today, we would like to focus on one population the National HIV/AIDS Strategy identifies as the group most affected by HIV and the only group in which the number of infections is growing, gay and bisexual men.
September 30, 2010
Washington, DC
